Literature DB >> 18493805

Activity of serum concentrations of daptomycin vs. vancomycin against vancomycin-susceptible and resistant Enterococcus faecium in the presence of albumin physiological concentrations: an in vitro pharmacodynamic simulation.

L Alou1, L Aguilar, M J Giménez, M Torrico, D Sevillano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18493805     DOI： 10.1007/s10096-008-0525-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.

Authors:  Luis Alou; María-José Giménez; David Sevillano; Lorenzo Aguilar; Fabio Cafini; Olatz Echeverría; Emilio Pérez-Trallero; José Prieto
Journal:  J Antimicrob Chemother       Date:  2006-06-16       Impact factor: 5.790

2.  Daptomycin dose-effect relationship against resistant gram-positive organisms.

Authors:  Raymond Cha; Richard G Grucz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Vancomycin tolerance in enterococci.

Authors:  Suat Saribas; Yasar Bagdatli
Journal:  Chemotherapy       Date:  2004-11-03       Impact factor: 2.544

4.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.

Authors:  H Hanberger; L E Nilsson; R Maller; B Isaksson
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.

Authors:  M J Rybak; E M Bailey; K C Lamp; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

6.  In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.

Authors:  F Cafini; L Aguilar; N González; M J Giménez; M Torrico; L Alou; D Sevillano; P Vallejo; J Prieto
Journal:  J Antimicrob Chemother       Date:  2007-04-05       Impact factor: 5.790

7.  Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.

Authors:  Barry H Dvorchik; David Brazier; Michael F DeBruin; Robert D Arbeit
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

8.  Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).

Authors:  Helio S Sader; Amy A Watters; Thomas R Fritsche; Ronald N Jones
Journal:  BMC Infect Dis       Date:  2007-04-18       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.